Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2003-05-15

AUTHORS

Xu Dong Zhang, Jodie M Borrow, Xi Yi Zhang, Tam Nguyen, Peter Hersey

ABSTRACT

We have previously shown that Smac/DIABLO release from mitochondria appears to be the principal pathway by which TRAIL induces apoptosis of human melanoma. We report that TRAIL-induced release of Smac/DIABLO appears to be downregulated by concomitant signaling through the MEK Erk1/2 kinase pathway and that this inhibits TRAIL-induced apoptosis. Inhibition of Erk1/2 signaling by either the MEK inhibitor U0126 or a dominant-negative mutant of MKK1 markedly sensitized melanoma cells to TRAIL-induced apoptosis. The site in the apoptotic pathway acted on by U0126 appeared to be downstream of caspase-8 and Bid but upstream of caspase-3 in that the levels of proteolytic cleavage of caspase-8 and Bid by TRAIL were similar in cells with or without exposure to U0126. Caspase-3 activation and cleavage of its substrates, PARP, ICAD and XIAP, were however increased by cotreatment with U0126. This was associated with a rapid reduction in mitochondrial transmembrane potential (MMP) and increased release of Smac/DIABLO into the cytosol. Exploration of events leading to the changes in MMP revealed an increased translocation of Bax from the cytosol to mitochondria in the presence of U0126. There was also a delayed decrease in the levels of expression of Mcl-1. Bcl-2 and Bcl-XL. Over expression of Bcl-2 blocked TRAIL-induced apoptosis in the presence of U0126. Cytochrome c appeared not to play a major role in sensitization of melanoma to TRAIL in that caspase-9 activation was not detected in most of the cell lines. These results suggest that Erk1/2 signaling may protect melanoma cells against TRAIL-induced apoptosis by inhibiting the relocation of Bax from the cytosol to mitochondria and that this may reduce TRAIL-mediated release of Smac/DIABLO and induction of apoptosis. More... »

PAGES

2869-2881

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.onc.1206427

DOI

http://dx.doi.org/10.1038/sj.onc.1206427

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1050315555

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12771938


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis Regulatory Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "BH3 Interacting Domain Death Agonist Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Butadienes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carrier Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Caspase 3", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Caspase 8", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Caspase 9", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Caspases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "In Vitro Techniques", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Intracellular Signaling Peptides and Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melanoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Membrane Glycoproteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mitochondria", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mitochondrial Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mitogen-Activated Protein Kinase 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mitogen-Activated Protein Kinase 3", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mitogen-Activated Protein Kinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nitriles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins c-bcl-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "TNF-Related Apoptosis-Inducing Ligand", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Necrosis Factor-alpha", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, Room 443, David Maddison Clinical Sciences Building, Cnr. King & Watt Streets, 2300, Newcastle, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Immunology and Oncology Unit, Room 443, David Maddison Clinical Sciences Building, Cnr. King & Watt Streets, 2300, Newcastle, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Xu Dong", 
        "id": "sg:person.01210116316.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210116316.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, Room 443, David Maddison Clinical Sciences Building, Cnr. King & Watt Streets, 2300, Newcastle, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Immunology and Oncology Unit, Room 443, David Maddison Clinical Sciences Building, Cnr. King & Watt Streets, 2300, Newcastle, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Borrow", 
        "givenName": "Jodie M", 
        "id": "sg:person.01140572250.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140572250.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, Room 443, David Maddison Clinical Sciences Building, Cnr. King & Watt Streets, 2300, Newcastle, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Immunology and Oncology Unit, Room 443, David Maddison Clinical Sciences Building, Cnr. King & Watt Streets, 2300, Newcastle, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Xi Yi", 
        "id": "sg:person.0677604026.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677604026.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, Room 443, David Maddison Clinical Sciences Building, Cnr. King & Watt Streets, 2300, Newcastle, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Immunology and Oncology Unit, Room 443, David Maddison Clinical Sciences Building, Cnr. King & Watt Streets, 2300, Newcastle, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nguyen", 
        "givenName": "Tam", 
        "id": "sg:person.0715242747.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715242747.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, Room 443, David Maddison Clinical Sciences Building, Cnr. King & Watt Streets, 2300, Newcastle, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Immunology and Oncology Unit, Room 443, David Maddison Clinical Sciences Building, Cnr. King & Watt Streets, 2300, Newcastle, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hersey", 
        "givenName": "Peter", 
        "id": "sg:person.01073667716.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073667716.42"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.cdd.4400998", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000342485", 
          "https://doi.org/10.1038/sj.cdd.4400998"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35051606", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052418104", 
          "https://doi.org/10.1038/35051606"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/20959", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031691936", 
          "https://doi.org/10.1038/20959"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/5517", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010598958", 
          "https://doi.org/10.1038/5517"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1205497", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010199811", 
          "https://doi.org/10.1038/sj.onc.1205497"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.cdd.4400783", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045467114", 
          "https://doi.org/10.1038/sj.cdd.4400783"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2003-05-15", 
    "datePublishedReg": "2003-05-15", 
    "description": "We have previously shown that Smac/DIABLO release from mitochondria appears to be the principal pathway by which TRAIL induces apoptosis of human melanoma. We report that TRAIL-induced release of Smac/DIABLO appears to be downregulated by concomitant signaling through the MEK Erk1/2 kinase pathway and that this inhibits TRAIL-induced apoptosis. Inhibition of Erk1/2 signaling by either the MEK inhibitor U0126 or a dominant-negative mutant of MKK1 markedly sensitized melanoma cells to TRAIL-induced apoptosis. The site in the apoptotic pathway acted on by U0126 appeared to be downstream of caspase-8 and Bid but upstream of caspase-3 in that the levels of proteolytic cleavage of caspase-8 and Bid by TRAIL were similar in cells with or without exposure to U0126. Caspase-3 activation and cleavage of its substrates, PARP, ICAD and XIAP, were however increased by cotreatment with U0126. This was associated with a rapid reduction in mitochondrial transmembrane potential (MMP) and increased release of Smac/DIABLO into the cytosol. Exploration of events leading to the changes in MMP revealed an increased translocation of Bax from the cytosol to mitochondria in the presence of U0126. There was also a delayed decrease in the levels of expression of Mcl-1. Bcl-2 and Bcl-XL. Over expression of Bcl-2 blocked TRAIL-induced apoptosis in the presence of U0126. Cytochrome c appeared not to play a major role in sensitization of melanoma to TRAIL in that caspase-9 activation was not detected in most of the cell lines. These results suggest that Erk1/2 signaling may protect melanoma cells against TRAIL-induced apoptosis by inhibiting the relocation of Bax from the cytosol to mitochondria and that this may reduce TRAIL-mediated release of Smac/DIABLO and induction of apoptosis.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.onc.1206427", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1097543", 
        "issn": [
          "0950-9232", 
          "1476-5594"
        ], 
        "name": "Oncogene", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "19", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "22"
      }
    ], 
    "keywords": [
      "Smac/DIABLO", 
      "mitochondrial transmembrane potential", 
      "Smac/DIABLO release", 
      "presence of U0126", 
      "DIABLO release", 
      "caspase-8", 
      "dominant negative mutant", 
      "translocation of Bax", 
      "melanoma cells", 
      "caspase-9 activation", 
      "ERK1/2 kinase pathway", 
      "relocation of Bax", 
      "Bcl-2", 
      "MEK inhibitor U0126", 
      "caspase-3 activation", 
      "induction of apoptosis", 
      "inhibition of ERK1/2", 
      "activation of ERK1/2", 
      "TRAIL-induced apoptosis", 
      "level of expression", 
      "kinase pathway", 
      "apoptotic pathway", 
      "inhibitor U0126", 
      "Bcl-xL", 
      "Mcl-1", 
      "U0126", 
      "mitochondria", 
      "proteolytic cleavage", 
      "cytochrome c", 
      "transmembrane potential", 
      "DIABLO", 
      "caspase-3", 
      "cytosol", 
      "apoptosis", 
      "cell lines", 
      "pathway", 
      "human melanoma", 
      "ERK1/2", 
      "principal pathway", 
      "Bax", 
      "cells", 
      "activation", 
      "expression", 
      "MKK1", 
      "cleavage", 
      "mutants", 
      "major role", 
      "XIAP", 
      "translocation", 
      "PARP", 
      "upstream", 
      "ICAD", 
      "trails", 
      "release", 
      "induction", 
      "inhibition", 
      "cotreatment", 
      "sites", 
      "levels", 
      "presence", 
      "role", 
      "substrate", 
      "rapid reduction", 
      "lines", 
      "melanoma", 
      "concomitant", 
      "events", 
      "relocation", 
      "bid", 
      "potential", 
      "changes", 
      "exposure", 
      "exploration of events", 
      "decrease", 
      "results", 
      "reduction", 
      "sensitization", 
      "exploration"
    ], 
    "name": "Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria", 
    "pagination": "2869-2881", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1050315555"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.onc.1206427"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12771938"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.onc.1206427", 
      "https://app.dimensions.ai/details/publication/pub.1050315555"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:50", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_376.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.onc.1206427"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1206427'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1206427'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1206427'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1206427'


 

This table displays all metadata directly associated to this object as RDF triples.

291 TRIPLES      21 PREDICATES      134 URIs      119 LITERALS      31 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.onc.1206427 schema:about N12f256ab53ed47da854c418f64d2a502
2 N227d905e8a694f7992417e3185394ed6
3 N2408c60a9377469fab06a815db7acba8
4 N2f36363f9dbb443fa5f5b3fb0b9afb4d
5 N2f46d3670700423fb7665fd82d1837fe
6 N3b47628e28dd4951ba7fbbfd37b5ea03
7 N42216ffdc5ee48f1ac6444f468f7622a
8 N5f66a206d5fb4e458dbb5c06db022c44
9 N62aa3b63c2b44c969c2e4459a00fa6c4
10 N6cc70340589748729a18344170fa93cc
11 N750bbfeb99184b08be55aaf20567be48
12 N7c386959601e494da80af0dfddbc1b3a
13 N8407bebe79b04498ab7c03bc06fddc0a
14 N8745059fa7ff43198bdec0406cb3a85f
15 N920b7abd1d974394bed4fc52c85ca871
16 Nbe149a5e676d4a598305a6dd4b307cce
17 Nbf50f9c791724344b99d3e522072122b
18 Nc9112195523e4ab2ae8cca258562b75d
19 Nd28459def78840b2a1128c38e03f94a2
20 Ne6e16b68ca9a4395a574b82eb8709ae2
21 Neabf07e44a314df7acfd221384865805
22 Neb44a86c568c4b689930e5ffe5f62325
23 Nfa20b36d21e141818a6dded6da9b518f
24 Nfb64cc67dd1141da9d14272734ba8486
25 anzsrc-for:11
26 anzsrc-for:1103
27 anzsrc-for:1112
28 schema:author Nc000fc4b4850487aab9fe99aadb9c8ab
29 schema:citation sg:pub.10.1038/20959
30 sg:pub.10.1038/35051606
31 sg:pub.10.1038/5517
32 sg:pub.10.1038/sj.cdd.4400783
33 sg:pub.10.1038/sj.cdd.4400998
34 sg:pub.10.1038/sj.onc.1205497
35 schema:datePublished 2003-05-15
36 schema:datePublishedReg 2003-05-15
37 schema:description We have previously shown that Smac/DIABLO release from mitochondria appears to be the principal pathway by which TRAIL induces apoptosis of human melanoma. We report that TRAIL-induced release of Smac/DIABLO appears to be downregulated by concomitant signaling through the MEK Erk1/2 kinase pathway and that this inhibits TRAIL-induced apoptosis. Inhibition of Erk1/2 signaling by either the MEK inhibitor U0126 or a dominant-negative mutant of MKK1 markedly sensitized melanoma cells to TRAIL-induced apoptosis. The site in the apoptotic pathway acted on by U0126 appeared to be downstream of caspase-8 and Bid but upstream of caspase-3 in that the levels of proteolytic cleavage of caspase-8 and Bid by TRAIL were similar in cells with or without exposure to U0126. Caspase-3 activation and cleavage of its substrates, PARP, ICAD and XIAP, were however increased by cotreatment with U0126. This was associated with a rapid reduction in mitochondrial transmembrane potential (MMP) and increased release of Smac/DIABLO into the cytosol. Exploration of events leading to the changes in MMP revealed an increased translocation of Bax from the cytosol to mitochondria in the presence of U0126. There was also a delayed decrease in the levels of expression of Mcl-1. Bcl-2 and Bcl-XL. Over expression of Bcl-2 blocked TRAIL-induced apoptosis in the presence of U0126. Cytochrome c appeared not to play a major role in sensitization of melanoma to TRAIL in that caspase-9 activation was not detected in most of the cell lines. These results suggest that Erk1/2 signaling may protect melanoma cells against TRAIL-induced apoptosis by inhibiting the relocation of Bax from the cytosol to mitochondria and that this may reduce TRAIL-mediated release of Smac/DIABLO and induction of apoptosis.
38 schema:genre article
39 schema:isAccessibleForFree false
40 schema:isPartOf N4da0ee35cb0142588153cc29711f78a2
41 Ncf7397f1f15b45b99e94df4a1377191b
42 sg:journal.1097543
43 schema:keywords Bax
44 Bcl-2
45 Bcl-xL
46 DIABLO
47 DIABLO release
48 ERK1/2
49 ERK1/2 kinase pathway
50 ICAD
51 MEK inhibitor U0126
52 MKK1
53 Mcl-1
54 PARP
55 Smac/DIABLO
56 Smac/DIABLO release
57 TRAIL-induced apoptosis
58 U0126
59 XIAP
60 activation
61 activation of ERK1/2
62 apoptosis
63 apoptotic pathway
64 bid
65 caspase-3
66 caspase-3 activation
67 caspase-8
68 caspase-9 activation
69 cell lines
70 cells
71 changes
72 cleavage
73 concomitant
74 cotreatment
75 cytochrome c
76 cytosol
77 decrease
78 dominant negative mutant
79 events
80 exploration
81 exploration of events
82 exposure
83 expression
84 human melanoma
85 induction
86 induction of apoptosis
87 inhibition
88 inhibition of ERK1/2
89 inhibitor U0126
90 kinase pathway
91 level of expression
92 levels
93 lines
94 major role
95 melanoma
96 melanoma cells
97 mitochondria
98 mitochondrial transmembrane potential
99 mutants
100 pathway
101 potential
102 presence
103 presence of U0126
104 principal pathway
105 proteolytic cleavage
106 rapid reduction
107 reduction
108 release
109 relocation
110 relocation of Bax
111 results
112 role
113 sensitization
114 sites
115 substrate
116 trails
117 translocation
118 translocation of Bax
119 transmembrane potential
120 upstream
121 schema:name Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria
122 schema:pagination 2869-2881
123 schema:productId N3c40bb3916d9494690342f527b2d46a3
124 N5e9753f1ab9d43cbb5f46e18e7765fde
125 Nd2b45a061c504467a709de3692d46215
126 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050315555
127 https://doi.org/10.1038/sj.onc.1206427
128 schema:sdDatePublished 2022-09-02T15:50
129 schema:sdLicense https://scigraph.springernature.com/explorer/license/
130 schema:sdPublisher N3b6b5fca69234376bf53e9b85c5fa7a0
131 schema:url https://doi.org/10.1038/sj.onc.1206427
132 sgo:license sg:explorer/license/
133 sgo:sdDataset articles
134 rdf:type schema:ScholarlyArticle
135 N12f08190e8044d139f34045b97d8565c rdf:first sg:person.0677604026.36
136 rdf:rest Nd5677f6f28484bc4a59d0d72d36fb53b
137 N12f256ab53ed47da854c418f64d2a502 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Caspase 8
139 rdf:type schema:DefinedTerm
140 N227d905e8a694f7992417e3185394ed6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Humans
142 rdf:type schema:DefinedTerm
143 N2408c60a9377469fab06a815db7acba8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Mitogen-Activated Protein Kinase 3
145 rdf:type schema:DefinedTerm
146 N2f36363f9dbb443fa5f5b3fb0b9afb4d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Membrane Glycoproteins
148 rdf:type schema:DefinedTerm
149 N2f46d3670700423fb7665fd82d1837fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Melanoma
151 rdf:type schema:DefinedTerm
152 N3b47628e28dd4951ba7fbbfd37b5ea03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Caspase 9
154 rdf:type schema:DefinedTerm
155 N3b6b5fca69234376bf53e9b85c5fa7a0 schema:name Springer Nature - SN SciGraph project
156 rdf:type schema:Organization
157 N3c40bb3916d9494690342f527b2d46a3 schema:name pubmed_id
158 schema:value 12771938
159 rdf:type schema:PropertyValue
160 N42216ffdc5ee48f1ac6444f468f7622a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name TNF-Related Apoptosis-Inducing Ligand
162 rdf:type schema:DefinedTerm
163 N4da0ee35cb0142588153cc29711f78a2 schema:issueNumber 19
164 rdf:type schema:PublicationIssue
165 N5d429c1f4b9442edb4a66efba0a9026e rdf:first sg:person.01140572250.01
166 rdf:rest N12f08190e8044d139f34045b97d8565c
167 N5e9753f1ab9d43cbb5f46e18e7765fde schema:name dimensions_id
168 schema:value pub.1050315555
169 rdf:type schema:PropertyValue
170 N5f66a206d5fb4e458dbb5c06db022c44 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Mitochondria
172 rdf:type schema:DefinedTerm
173 N62aa3b63c2b44c969c2e4459a00fa6c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Apoptosis Regulatory Proteins
175 rdf:type schema:DefinedTerm
176 N6cc70340589748729a18344170fa93cc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Apoptosis
178 rdf:type schema:DefinedTerm
179 N750bbfeb99184b08be55aaf20567be48 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Butadienes
181 rdf:type schema:DefinedTerm
182 N7c386959601e494da80af0dfddbc1b3a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Caspases
184 rdf:type schema:DefinedTerm
185 N8407bebe79b04498ab7c03bc06fddc0a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Tumor Necrosis Factor-alpha
187 rdf:type schema:DefinedTerm
188 N8745059fa7ff43198bdec0406cb3a85f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Mitogen-Activated Protein Kinases
190 rdf:type schema:DefinedTerm
191 N920b7abd1d974394bed4fc52c85ca871 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Intracellular Signaling Peptides and Proteins
193 rdf:type schema:DefinedTerm
194 N9a0a3986a1284816bb4a536880ba1c1f rdf:first sg:person.01073667716.42
195 rdf:rest rdf:nil
196 Nbe149a5e676d4a598305a6dd4b307cce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Nitriles
198 rdf:type schema:DefinedTerm
199 Nbf50f9c791724344b99d3e522072122b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Caspase 3
201 rdf:type schema:DefinedTerm
202 Nc000fc4b4850487aab9fe99aadb9c8ab rdf:first sg:person.01210116316.18
203 rdf:rest N5d429c1f4b9442edb4a66efba0a9026e
204 Nc9112195523e4ab2ae8cca258562b75d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
205 schema:name Proto-Oncogene Proteins c-bcl-2
206 rdf:type schema:DefinedTerm
207 Ncf7397f1f15b45b99e94df4a1377191b schema:volumeNumber 22
208 rdf:type schema:PublicationVolume
209 Nd28459def78840b2a1128c38e03f94a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
210 schema:name BH3 Interacting Domain Death Agonist Protein
211 rdf:type schema:DefinedTerm
212 Nd2b45a061c504467a709de3692d46215 schema:name doi
213 schema:value 10.1038/sj.onc.1206427
214 rdf:type schema:PropertyValue
215 Nd5677f6f28484bc4a59d0d72d36fb53b rdf:first sg:person.0715242747.02
216 rdf:rest N9a0a3986a1284816bb4a536880ba1c1f
217 Ne6e16b68ca9a4395a574b82eb8709ae2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
218 schema:name Cell Line
219 rdf:type schema:DefinedTerm
220 Neabf07e44a314df7acfd221384865805 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
221 schema:name Mitogen-Activated Protein Kinase 1
222 rdf:type schema:DefinedTerm
223 Neb44a86c568c4b689930e5ffe5f62325 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
224 schema:name Carrier Proteins
225 rdf:type schema:DefinedTerm
226 Nfa20b36d21e141818a6dded6da9b518f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
227 schema:name In Vitro Techniques
228 rdf:type schema:DefinedTerm
229 Nfb64cc67dd1141da9d14272734ba8486 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
230 schema:name Mitochondrial Proteins
231 rdf:type schema:DefinedTerm
232 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
233 schema:name Medical and Health Sciences
234 rdf:type schema:DefinedTerm
235 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
236 schema:name Clinical Sciences
237 rdf:type schema:DefinedTerm
238 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
239 schema:name Oncology and Carcinogenesis
240 rdf:type schema:DefinedTerm
241 sg:journal.1097543 schema:issn 0950-9232
242 1476-5594
243 schema:name Oncogene
244 schema:publisher Springer Nature
245 rdf:type schema:Periodical
246 sg:person.01073667716.42 schema:affiliation grid-institutes:None
247 schema:familyName Hersey
248 schema:givenName Peter
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073667716.42
250 rdf:type schema:Person
251 sg:person.01140572250.01 schema:affiliation grid-institutes:None
252 schema:familyName Borrow
253 schema:givenName Jodie M
254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140572250.01
255 rdf:type schema:Person
256 sg:person.01210116316.18 schema:affiliation grid-institutes:None
257 schema:familyName Zhang
258 schema:givenName Xu Dong
259 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210116316.18
260 rdf:type schema:Person
261 sg:person.0677604026.36 schema:affiliation grid-institutes:None
262 schema:familyName Zhang
263 schema:givenName Xi Yi
264 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677604026.36
265 rdf:type schema:Person
266 sg:person.0715242747.02 schema:affiliation grid-institutes:None
267 schema:familyName Nguyen
268 schema:givenName Tam
269 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715242747.02
270 rdf:type schema:Person
271 sg:pub.10.1038/20959 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031691936
272 https://doi.org/10.1038/20959
273 rdf:type schema:CreativeWork
274 sg:pub.10.1038/35051606 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052418104
275 https://doi.org/10.1038/35051606
276 rdf:type schema:CreativeWork
277 sg:pub.10.1038/5517 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010598958
278 https://doi.org/10.1038/5517
279 rdf:type schema:CreativeWork
280 sg:pub.10.1038/sj.cdd.4400783 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045467114
281 https://doi.org/10.1038/sj.cdd.4400783
282 rdf:type schema:CreativeWork
283 sg:pub.10.1038/sj.cdd.4400998 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000342485
284 https://doi.org/10.1038/sj.cdd.4400998
285 rdf:type schema:CreativeWork
286 sg:pub.10.1038/sj.onc.1205497 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010199811
287 https://doi.org/10.1038/sj.onc.1205497
288 rdf:type schema:CreativeWork
289 grid-institutes:None schema:alternateName Immunology and Oncology Unit, Room 443, David Maddison Clinical Sciences Building, Cnr. King & Watt Streets, 2300, Newcastle, NSW, Australia
290 schema:name Immunology and Oncology Unit, Room 443, David Maddison Clinical Sciences Building, Cnr. King & Watt Streets, 2300, Newcastle, NSW, Australia
291 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...